C-Path
0762.683.482 · rovalta.com · 22/09/2026
ACTIVE
C-Path
Financial year 2025 · closed on 31/12/2025
Net result
-537,3 k €
-74.6% YoY
Gross margin
15,2 k €
-91.0% YoY
Equity
-287,6 k €
+52.8% YoY
Workforce
2,3 ETP
-17.9% YoY
Overview
What does C-Path do?
C-Path is a Private limited company incorporated in 2021. Its main activity is: Computer programming activities. Its registered office is in Diepenbeek. It employs on average 2,3 ETP workers (FTE).
Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0762.683.482
Incorporation
29/01/2021
Legal form
Private limited company
Registered office
Agoralaan Abis
3590 Diepenbeek · FlandreSee on map
3590 Diepenbeek · FlandreSee on map
Contributed capital
859 685,87 €
Latest accounts
31/12/2025
Average workforce
2,3 ETP
Activities (NACE)
62010Computer programming activities· main62100Computer programming, consultancy and related activities72101Research and experimental development on natural sciences and engineering72110Research and experimental development on biotechnology63100Data processing, hosting and related activities; web portals63110Data processing, hosting and related activities
Joint committees (2)
- 207
- 330
Signals
Healthy social debts
Available with a Rovalta subscriptionTry for 7 days
Financials
Trend over 5 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 15,2 k € | -91.0% | 168,6 k € | -6.6% | 180,4 k € | -20.9% | 228,1 k € | +191% | 78,3 k € |
| EBITDA | -160,5 k € | -593% | -23,2 k € | +59.8% | -57,7 k € | -958% | 6,7 k € | -65.2% | 19,3 k € |
| Operating result | -512,3 k € | -92.5% | -266,2 k € | -18.3% | -225 k € | -230% | -68,1 k € | -2142% | 3,3 k € |
| Net result | -537,3 k € | -74.6% | -307,7 k € | -28.0% | -240,5 k € | -231% | -72,7 k € | -769% | 10,9 k € |
| Balance sheet | |||||||||
| Equity | -287,6 k € | +52.8% | -609 k € | -102% | -301,3 k € | -395% | -60,9 k € | -613% | 11,9 k € |
| Total assets | 622,3 k € | -33.7% | 938,4 k € | -10.1% | 1 M € | +93.3% | 540,2 k € | +54.9% | 348,8 k € |
| Cash | 15,6 k € | -41.8% | 26,8 k € | +96.9% | 13,6 k € | +36.6% | 10 k € | -84.8% | 65,4 k € |
| Debts | 796,6 k € | -46.8% | 1,5 M € | +15.7% | 1,3 M € | +118% | 593,6 k € | +81.7% | 326,8 k € |
| Other | |||||||||
| Workforce | 2,3 ETP | -17.9% | 2,8 ETP | -15.2% | 3,3 ETP | +17.9% | 2,8 ETP | +55.6% | 1,8 ETP |
Governance
Board of directors
Seen on filing of 31/12/2025 · 2 active · 4 ended
Active mandates
Active
Active
Ended mandates
At this address
Other companies at this address
| Company | CBE no. |
|---|---|
Bedal International● Active | 0841.685.826 |
BIOCLUE● Active | 0719.914.105 |
BIOKEY● Active | 0719.913.808 |
BIOSTRAND● Active | 0719.913.907 |
Clinitude● Active | 0478.640.857 |
FOx Biosystems● Bankrupt | 0653.744.366 |
Highstar Engineering● Active | 0685.983.703 |
IDEA FAMILY● Active | 0719.674.177 |
NanoBiotech● Active | 1023.651.490 |
Presscuff● Active | 0800.361.153 |
Reprosci Biosciences● Active | 1008.398.241 |
Sealantium Medical Belgium● Active | 1012.599.727 |
SIMABS● Active | 0732.709.096 |
| 1011.224.604 | |
StingOrg● Active | 0804.587.383 |
Financials
Annual accounts
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 28/01/2021 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 23/06/2026 | 30/06/2025 | 27/06/2024 | 08/06/2023 | 18/07/2022 |
| General meeting | 05/06/2026 | 06/06/2025 | 07/06/2024 | 02/06/2023 | 03/06/2022 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Ratios
Financial ratios
Looking for more information about this company?
Try for 7 daysFilings
Annual accounts filings
5 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 05/06/2026 | 23/06/2026 | Dutch | |
| Abridged model | 31/12/2024 | 06/06/2025 | 30/06/2025 | Dutch | |
| Abridged model | 31/12/2023 | 07/06/2024 | 27/06/2024 | Dutch | |
| Abridged model | 31/12/2022 | 02/06/2023 | 08/06/2023 | Dutch | |
| Abridged model | 31/12/2021 | 03/06/2022 | 18/07/2022 | Dutch |
Valuation
Estimate
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Governance
Board of directors
Seen on filing of 31/12/2025 · 2 active · 4 ended
Active mandates
Active
Active
Ended mandates
Shareholders
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette
Belgian Official Gazette publications
Source: Belgian Official Gazette
Similar companies
Competition
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025-537,3 k €↓
- 2024Annual accounts 2024-307,7 k €↓
- 2023Annual accounts 2023-240,5 k €↓
- 2022Annual accounts 2022-72,7 k €↓
- 2021Annual accounts 202110,9 k €
- 29/01/2021IncorporationPrivate limited company